Clinical Trials Browser

INDUSTRY × Solid Neoplasms × pembrolizumab × Clear all

NCT04420884 2025-06-13

iintune-1

Phase 1/2 Active not recruiting

Solid Neoplasms

NCT03364049 2021-11-15

MK-7162-002

Phase 1 Completed

33 enrolled 19 charts

Solid Neoplasms